Stem Cell Therapeutic and Research Reauthorization Act of 2026

Summary

Stem Cell Therapeutic and Research Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of high-quality cord blood units and other emergent technologies to develop new therapies for potential inclusion in the program. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Out of committee and scheduled for a vote by the full chamber.

Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Related bills

• H.R. 5160Stem Cell Therapeutic and Research Reauthorization Act of 2025Related bill

As identified by Congress.gov.

Full history

1. Jun 22, 2026

   Reported out of committee

   Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

2. Jun 22, 2026

   Reported out of committee

   Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

3. Jun 22, 2026

   Reported out of committee

   Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

4. Jun 22, 2026

   Introduced

   Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

   U.S. Senate

5. Jun 22, 2026

   Placed on Senate Legislative Calendar Under General Orders. Calendar No. 443.

   Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

   U.S. Senate

Read the record

• Read on Congress.gov (opens in a new tab) The official record on Congress.gov.